Lab to Impact: The Hard Reality of Building a Biotech Startup – A CEO’s Perspective

What does it really take to build a biotech startup?

Join us for a candid conversation with serial entrepreneur Laurence Blumberg, M.D., as he shares firsthand insights from decades of building and leading life sciences companies—from early-stage innovation to acquisition.

This session will go beyond the typical startup narrative to explore the realities of biotech entrepreneurship: long timelines, scientific uncertainty, capital intensity, and the decisions that shape successful ventures.

Whether you are a researcher, inventor, or aspiring founder, this session will provide a grounded perspective on what it takes to translate scientific discoveries into viable companies.

Hosted by Lynda Inseque, director of Technology & Venture Initiatives and Engagement at CTL.

Register here.